Epidemiology of Cancer Healthcare Outcomes (ECHO) Research Group, Research Department of Behavioural Science and Health, University College London, London, United Kingdom.
National Disease Registration Service, NHS Digital, Leeds, West Yorkshire, United Kingdom.
Fam Pract. 2022 Jul 19;39(4):623-632. doi: 10.1093/fampra/cmab139.
There is uncertainty regarding how pre-existing conditions (morbidities) may influence the primary care investigation and management of individuals subsequently diagnosed with cancer.
We identified morbidities using information from both primary and secondary care records among 11,716 patients included in the English National Cancer Diagnosis Audit (NCDA) 2014. We examined variation in 5 measures of the diagnostic process (the primary care interval, diagnostic interval, number of pre-referral consultations, use of primary care-led investigations, and referral type) by both primary care- and hospital records-derived measures of morbidity.
Morbidity prevalence recorded before cancer diagnosis was almost threefold greater using the primary care (75%) vs secondary care-derived measure (28%). After adjustment, there was limited variation in the primary care interval and the number of pre-referral consultations by either definition of morbidity. Patients with more severe morbidities were less likely to have had a primary care-led investigation before cancer diagnosis compared with those without any morbidity (adjusted odds ratio, OR [95% confidence interval]: 0.72 [0.60-0.86] for Charlson score 3+ vs 0; joint P < 0.001). Patients with multiple primary care-recorded conditions or a Charlson score of 3+ were more likely to have diagnostic intervals exceeding 60 days (aOR: 1.26 [1.10-1.45] and 1.19 [>1.00-1.41], respectively), and more likely to receive an emergency referral (aOR: 1.60 [1.26-2.02] and 1.61 [1.26-2.06], respectively).
Among cancer cases with up to 2 morbidities, there was no evidence of differences in diagnostic processes and intervals in primary care but higher morbidity burden was associated with longer time to diagnosis and higher likelihood of emergency referral.
对于先前存在的疾病(合并症)如何影响随后被诊断为癌症的个体的初级保健调查和管理,目前尚存在不确定性。
我们在 2014 年英国国家癌症诊断审计(NCDA)中纳入的 11716 例患者的初级和二级保健记录中,使用信息确定了合并症。我们根据初级保健记录和医院记录中获得的合并症测量值,检查了诊断过程的 5 个指标(初级保健间隔、诊断间隔、转诊前就诊次数、初级保健主导的检查使用情况和转诊类型)的变化情况。
使用初级保健记录(75%)与二级保健记录相比,癌症诊断前记录的合并症患病率几乎增加了两倍(28%)。在调整后,无论使用哪种合并症定义,初级保健间隔和转诊前就诊次数的变化均有限。与无任何合并症的患者相比,患有更严重合并症的患者在癌症诊断前更不可能接受初级保健主导的检查(调整后的比值比[95%置信区间]:Charlson 评分 3+者为 0.72 [0.60-0.86];两者联合 P < 0.001)。有多个初级保健记录的疾病或 Charlson 评分 3+的患者更有可能出现超过 60 天的诊断间隔(比值比:1.26 [1.10-1.45]和 1.19 [>1.00-1.41]),且更有可能获得急诊转诊(比值比:1.60 [1.26-2.02]和 1.61 [1.26-2.06])。
在有多达 2 种合并症的癌症病例中,初级保健的诊断过程和间隔没有差异的证据,但更高的合并症负担与诊断时间延长和急诊转诊的可能性增加有关。